[HTML][HTML] An outcome-based follow-up study of cured category I pulmonary tuberculosis adult cases from various tuberculosis units under revised national tuberculosis …
…, P Patel, B Patel, S Gajjar, N Bapat - Indian Journal of …, 2019 - journals.lww.com
Objectives: The main objectives of this study is (1) To find the response of treatment in terms
of failure and drug resistance (recurrence of symptoms and mortality experience) and (2) …
of failure and drug resistance (recurrence of symptoms and mortality experience) and (2) …
Way ahead-post Covid-19 lockdown in India
COVID 19 pandemic is a global health emergency which every country is grappling with
since beginning of this year. Countries have their own strategies to cope with the cases and …
since beginning of this year. Countries have their own strategies to cope with the cases and …
Effect of COVID-19 during pregnancy: Studying the maternal and neonatal outcomes and assessing the placental changes related to SARS-CoV-2
…, R Chovatiya, P Dabhi, M Patel, A Patel, N Bapat… - medRxiv, 2022 - medrxiv.org
Background Pregnant females affected with COVID-19 are reported to have poorer disease
outcomes as compared to non-pregnant females of a similar age group. COVID-19 may lead …
outcomes as compared to non-pregnant females of a similar age group. COVID-19 may lead …
[HTML][HTML] Profile of reproductive tract infections among attendees of reproductive tract infection/sexually transmitted infection clinic in a Tertiary Care Institute of …
…, MM Rana, KB Patel, N Bapat - Indian Journal of …, 2019 - journals.lww.com
According to the World Health Organization estimates, more than 1 million sexually transmitted
infections (STIs) are acquired every day among which chlamydia, gonorrhea, syphilis, …
infections (STIs) are acquired every day among which chlamydia, gonorrhea, syphilis, …
A qualitative study regarding perception and challenges faced by providers and beneficiaries of Rashtriya Bal Swasthya Karyakram in general and also amid the …
…, D Oza, R Dave, D Jani, N Bapat - MRIMS Journal of …, 2023 - journals.lww.com
Background: During COVID-19 pandemic, service providers and beneficiaries of Rashtriya
Bal Swasthya Karyakram (RBSK) faced certain challenges. Objectives: The objective was to …
Bal Swasthya Karyakram (RBSK) faced certain challenges. Objectives: The objective was to …
Evaluating the efficacy of tocilizumab in moderate to severe COVID-19 with progressive illness despite steroids: identifying the optimal timing of its administration in …
…, M Patel, H Shah, R Chovatiya, M Soni, N Bapat… - medRxiv, 2020 - medrxiv.org
Background High mortality has been described in coronavirus disease 2019 (COVID-19)
with cytokine release syndrome (CRS). Tocilizumab (TCZ), an interleukin-6 (IL-6) receptor …
with cytokine release syndrome (CRS). Tocilizumab (TCZ), an interleukin-6 (IL-6) receptor …
[HTML][HTML] Profile, Quality of Life and the Client Satisfaction of Beneficiaries Registered under Rashtriya Bal Swasthya Karyakram (RBSK) at an Urban Primary Health …
…, R Dave, A Pirzada, D Jani, N Bapat… - Indian Journal of …, 2022 - journals.lww.com
Background: Under Rashtriya Bal Swasthya Karyakram (RBSK), children (0–18 years) are
screened for a spectrum of 30 health conditions, categorized under 4D’s namely defect (birth), …
screened for a spectrum of 30 health conditions, categorized under 4D’s namely defect (birth), …
Remdesivir for the treatment of COVID-19 disease: A retrospective comparative study of patients treated with and without Remdesivir
…, V Sankhla, V Kapoor, T Patel, M Soni, N Bapat… - medRxiv, 2021 - medrxiv.org
Background Remdesivir (RDV) in coronavirus disease 2019 (COVID-19) has been found to
be beneficial in patients with severe disease; however, its role in mild-moderate disease and …
be beneficial in patients with severe disease; however, its role in mild-moderate disease and …
[PDF][PDF] Maternal determinants for 4 Ds in children registered under Rashtriya Bal Swasthya Karyakram program at an urban health centre of Ahmedabad
…, D Oza, A Pirzada, D Jani, N Bapat - International Journal of …, 2023 - academia.edu
Background: Maternal determinants influence the outcome of pregnancy and child’s health
in early years. Rashtriya Bal Swasthya Karyakram (RBSK) deals with the 4 D (birth defects, …
in early years. Rashtriya Bal Swasthya Karyakram (RBSK) deals with the 4 D (birth defects, …
Clinical Efficacy and Safety of Oral Apremilast: Treatment Analysis for Chronic Plaque Psoriasis
…, A Modasiya, A Patel, N Bapat… - Journal of …, 2022 - go7publish.com
Background: Apremilast is an oral, selective phosphodiesterase-4 (PDE-4) enzyme inhibitor,
approved by the US-FDA for management of moderate to severe plaque psoriasis. …
approved by the US-FDA for management of moderate to severe plaque psoriasis. …